Alumis Inc

Alumis insider buying: Chief Legal Officer Pang Sanam’s 186K option purchase signals confidence amid volatile biotech stock.

Alumis insider buying surge: AK KaraJ Srinivas buys 588K shares at $17, showing confidence in a post‑funding upsized offer and potential upside beyond current losses.

Foresite Capital’s $17 stock buys show strong confidence in Alumis, a clinical‑stage biotech with a promising TYK2 pipeline—learn what this means for short‑term gains and long‑term prospects.